News & Press

Patient Support Programs—Providing Help Beyond Financial Support

Posted by | Fuld & Company

Varun Naik was called upon by PM360 to share best practices on Effectively Developing a Patient Support Program by Leveraging Competitive Intelligence (CI) tactics. He also covers this topic broadly in a Fuld & Company whitepaper.

Patient Support Programs | Varun Naik, Fuld & Company

An effective PSP is critical to a drug’s success and requires significant resources to develop and manage.

Therefore, organizations must make the right investment decisions with a focus on the patient’s needs, especially as patients play a stronger role in their treatment decisions. Executives must also identify elements that create exceptional value for patients and meet the needs of healthcare offices.

Developing a robust strategy for a patient support program begins with assessing the current environment.

By benchmarking existing programs and pinpointing their areas of improvement, companies can leverage insights to refine their approach and create a competitive advantage. While all programs tend to include the same basic elements, there is no one size fits all approach, as experiences differ by indication. However, some success criteria Fuld & Company has identified for all patient support programs are…

 

 

About Varun Naik

Varun Naik serves as Director in the Life Science Consulting practice at Fuld & Company. He specializes in rare disease, biosimilars and other pharma related topics.

Tags: , , ,

Related Resources

Read More

Automotive leader Jan Ellsberger joins Fuld as Advisory Board Member

BOSTON – February 20, 2024 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment […]

Read More

Amie Stark Joins Fuld & Company as VP Client Success

LONDON – July 12, 2023 – Fuld & Company, an expanding research, analytics, and advisory consultancy, is pleased to welcome […]

Read More

Charles Collier Joins Fuld & Company as Senior Vice President, Consulting Research & Analytics

BOSTON – Jan 24, 2023 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment […]

Subscribe to our mailing list for our latest updates: